Sign in
4

Changes in Ownership

Teladoc Health, Inc. Filed Acc 0001415889-23-004409

SVP - CORPORATE DEVELOPMENT sold 1,795 shares at $25.91 ($46,510)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Turitz Andrew SVP - CORPORATE DEVELOPMENT 2023-03-03 Sale −1,795 $25.91 $46,510 22,806 D
Derivatives
Turitz Andrew SVP - CORPORATE DEVELOPMENT 2023-03-03 Grant or award · Restricted Stock Units +37,202 37,202 D
Open-market sales · 1,795 sh · avg $25.91 · $46,510
Loading xslF345X03/form4-03072023_090301.xml…